semaglutide
Study Finds GLP-1 Drug Semaglutide Linked to Lower Risk of Mental Health Issues
New research links Semaglutide, a GLP-1 weight-loss drug, to lower rates of depression, anxiety, and self-harm. The finding points to potential mental health benefits requiring further study.
Generic Semaglutide to Cut Weight-Loss Drug Prices Dramatically Across Several Countries
Semaglutide weight-loss drugs will soon be available in generic forms in India, China, and Turkey. This could drastically reduce costs and improve accessibility, though patent and legal challenges remain a concern for equitable distribution.
Study Finds Diabetes Drug Semaglutide May Prevent Worsening Anxiety and Depression
Studies find semaglutide, a diabetes and weight-loss drug, may reduce anxiety and depression symptoms. These findings highlight potential dual benefits, offering new treatment pathways for metabolic and mental health conditions.
US Dominates Global Weight-Loss Injection Trend; Low-Cost Jab Development on Horizon
The United States leads worldwide in the adoption of weight-loss injections, reflecting a booming market. Meanwhile, a study proposes a low-cost $3/month drug that could be a game-changer for global obesity treatment.